Stem cells and stem cell therapy work by paracrine signaling (local cell-to-cell communication to induce changes in nearby cells) to create the appropriate healing environment to restore tissue. The exosomes are those paracrine signals that can be delivered immediately. As the technology and discovery of new methods of treating patients has evolved, the science shows that the optimal way to provide true “stem cell therapy” is to directly provide the signals as its own therapy and avoid potential issues with delivering and keeping transplanted cells alive.

Stem cells by nature work to heal, repair, and restore the body. Exosomes, found in healthy tissue, have shown 1000+ Growth Factor Proteins to help modulate the inflammatory healing process. This is accomplished by activating and recruiting the patients’ own cells to the area, revascularizing the area and reducing the inflammatory response to allow natural healing



Learn More


Wharton’s Jelly Tissue Allograft is extracted and processed to yield a high concentration of:

Mesenchymal Stem Cells (MSC’s), Cytokines, Growth Factors, Hyaluronic Acid, Specialized cells for signaling, Scaffolding cells necessary to reconstruct, repair, replace, or supplement damaged/injured tissue.

Vitacell Biologics Wharton’s Jelly tissue allograft strictly adhere’s to the FDA’s Regulatory Criteria and section 361 of the PHS Act for Minimal Manipulation, 21 CFR 1271.10(a)(1) and Homologous Use, 21 CFR 1271.10(a)(2). 

Vitacell Pro

Vitacell Pro

Learn More

Vitacell Pro

VITACELL PRO has the highest concentration of all tissue allografts .

Wharton’s Jelly Tissue Allograft is extracted and processed to yield a high concentration of:

Mesenchymal Stem Cells (MSC’s), Cytokines, Growth Factors, Hyaluronic Acid, Specialized cells for signaling, Scaffolding cells necessary to reconstruct, repair, replace, or supplement damaged/injured tissue.

Vitacell Biologics Wharton’s Jelly tissue allograft strictly adhere’s to the FDA’s Regulatory Criteria and section 361 of the PHS Act for Minimal Manipulation, 21 CFR 1271.10(a)(1) and Homologous Use, 21 CFR 1271.10(a)(2).

Cytocell Pro

Cytocell Pro

Learn More

Cytocell Pro

25 and 50 billion Exosomes.  

Exosomes are not cells but are micro-vesicles, which are about 1/1,000th the size of a cell and contain no nucleus or DNA. They can be regarded as the purest form of cellular therapy available because their function is to direct tissue and wound healing by activating the patient’s own regenerative cell response.


"Fountain of Youth" ( in a bottle )

Learn More

Nutrify CELL

Ground Breaking, All Natural, Anti-Aging Rejuvenating Blend

We've partnered with Katerina Kennedy to bring you Nutrify CELL ! 

Katerina Kennedy, the founder of Nutrify CELL, has devoted her life to fitness, health, and nutrition. Her background as a competitive bodybuilder, fitness model, and diet and nutrition guru means she knows a thing or two about supplements. But she couldn’t find one with the comprehensive care she wanted.

So she developed Nutrify CELL. This revolutionary powder supplement targets free radicals to help reverse and prevent cell oxidation.

Her custom blend of amino acids, antioxidants, and herbs is clinically tested and ethically and domestically produced at a premium laboratory in Atlanta. It’s like the fountain of youth in a bottle. 

This high quality, all natural rejuvenating blend is in such high demand that we are completely sold out ! We are presently taking orders and will immediately ship to those who place orders through this portal. CALL us at 855-696-CELL (2355) and ask for Katerina. We will immediately reach out to you to fulfill your request.

Screenshot 2023 06 18 at 7.52.02 PM

Ground breaking Regenerative Facial / Skin Treatments

Ground breaking Regenerative Facial / Skin Treatments

Learn More




Testing Guidelines

We continue to “exceed” industry standards for testing. All of our products are sent for sterility, endotoxin, and environmental testing by a third-party laboratory that is a global leader in pharmaceutical, cosmetic, and environmental testing arena.

Our Testing Guidelines

  1. USP 71 Sterility Guidelines (All Fungus, Mold, Yeast, Bacteria) in accordance with AATB and FDA guidelines.
  2. Endotoxin guidelines and environmental testing in accordance with AATB and FDA guidelines.
  3. Viruses, blood, and tissue borne pathogens in accordance with AATB and FDA guidelines including HIV, HBsAg, HCV, HBc Total, HTLV I/II, RPR, HIV/HCV/HBV Ultrio, WNV NAT, CMV Ab, Zika NAT, Lyme Disease, Epstein-Barr Virus, E.coli, Candida, and COVID-19.

Regulatory Standards

Regulatory standards are important for public safety and product quality. Learn more about some of the regulatory bodies we work with to maintain compliance and integrity.

Payne Authorized Dealer


Using our Proprietary Patented Processing techniques and following minimally manipulative procedures, our process does not alter the regenerative properties of the placental tissue. Our products maintain the integrity of the original source material and the relevant characteristics relating to its utility for soft tissue supplementation that is required for tissue repair.

  • All products undergo independent sterility testing and are manufactured in a GMP & GTP Facility.
  • VITACELL BIOLOGICS is HCT/P compliant under Section 361 of the Public Health Service Act according to 21 CFR Part 1271.10. They are regulated as a human cell and tissue product – for homologous use only.
  • Prescription use only for sale to licensed healthcare professionals.



Our Team are experts nationally and internationally for their skill and expertise in not only providing the “Purest products” in the world, but for also training our practitioners on the current protocols, procedures and techniques associated with the regenerative medicine arena.  We provide the best products world-wide and believe research is invaluable and are constantly engaged in peer, physician, and patient collaboration.  We set the standards for excellence by “exceeding” all federal and state regulatory guidelines through a proactive approach.  We consistently and regularly test our products and facility to ensure we maintain and exceed the industry standards.

  • VITACELL BIOLOGICS only accepts bio-ethically donated birth tissue from healthy consenting mothers in the United States who have passed a comprehensive medical background check, blood screenings, and have full-term, live, C-section births. In addition, we only work with tissue procurement organizations within the United States who use collection techniques that follow the AATB guidelines, prioritizing the health and safety of the mother and baby above procurement. We strive to have an FDA and AATB compliant supply chain and the highest quality procurement.

  • VITACELL BIOLOGICS implements and maintains quality and regulatory assurance in alignment with FDA (Federal Drug Administration) regulations. We do so by building strict protocols to uphold these requirements. In addition, we follow the guidelines set forth by the AATB (American Association of Tissue Banking), cGMP (Current Good Manufacturing Practices), GTP (Good Tissue Practices), and WHO (World Health Organization), while exceeding the protocols and procedures to meet applicable requirements.

  • Dr. Mark Fedorczyk, DC, FSCT


    As a pioneer in the field of Regenerative Medicine, he has empowered thousands with his innovative approach. He has committed his life to assisting others in enhancing their health and vitality.
    With over 30 years of practice under his belt, Dr. Mark Fedorczyk, DC, FSCT, is a respected authority in the field of Regenerative Medicine. Known fondly as "The Stem Cell Doc" or "Dr. Mark," he is renowned for his specialized expertise in musculoskeletal and soft tissue injuries. He holds advanced training in radiology, diagnostic ultrasound, and has earned his Fellowship in Stem Cell Therapy.

    Dr. Mark’s mission is to help individuals regain their health and live the quality of life they were designed for. His dedication has led patients from all corners of the globe to seek his expert care. Beyond his clinical work, he plays an instrumental role in the development of Regenerative Medicine. He collaborates with global medical professionals to research and design protocols for various applications of stem cells and exosomes and has trained hundreds of doctors in the field.

    Having treated thousands of patients, Dr. Mark's profound knowledge and experience shape the transformative future of healthcare. His insights have the potential to not only change your life but also significantly impact the lives of your loved ones.

    Gary Kiss

    International Development Director

    Gary Kiss

    Gary Kiss has been at the forefront of business development in Regenerative biotech, peptides, and also bio photonics. He is now a pioneer of integrating AI into the preventative wellness industry. Kiss combines visionary and professional knowledge and resources in order to keep the medical professionals and public at the cutting edge of preventative health.

    Nancy Nyugen

    Vitacell Biologics Head of Vietnamese Development

    [Nancy Nyugen]


Clinical Research


    The umbilical cord has become an increasingly used source of mesenchymal stromal cells for preclinical and, more recently, clinical studies. Despite the increased activity, several aspects of this cell population have been under-appreciated. Key issues are that consensus on the anatomical structures within the cord is lacking, and potentially different populations are identified as arising from a single source. To help address these points, we propose a histologically based nomenclature for cord structures and provide an analysis of their developmental origins and composition. Methods of cell isolation from Wharton’s jelly are discussed and the immunophenotypic and clonal characteristics of the cells are evaluated. The perivascular origin of the cells is also addressed. Finally, clinical trials with umbilical cord cells are briefly reviewed. Interpreting the outcomes of the many clinical studies that have been undertaken with mesenchymal stromal cells from different tissue sources has been challenging, for many reasons. It is, therefore, particularly important that as umbilical cord cells are increasingly deployed therapeutically, we strive to better understand the derivation and functional characteristics of the cells from this important tissue source. 



    The connective tissue of the human umbilical cord, Wharton’s jelly, is garnering increasing attention as a source of mesenchymal stromal cells


    Wharton’s jelly is among the simplest of human connective tissues, and provides an apparently more homogeneous harvested cell population than other mesenchymal tissue sources.

    Click on the link below to view this article.

  • Abstract

    Once cartilage is damaged, it has limited potential for self-repair. Autologous chondrocyte implantation is an effective treatment, but patients may suffer during cartilage harvesting and the donor-site morbidity may accelerate joint degeneration. Using autologous mesenchymal stem cells (MSCs) derived chondrocytes is another selection, while it also causes some injuring. The umbilical cord, an ecto-embryo tissue may be an ideal source of cells, because of its accessibility, abundant resources, painless procedures for harvesting, and lack of ethical issues. We isolated MSCs from Wharton’s jelly of human umbilical cord (WMSCs), which expressed CD44, CD105 and CD271 but not CD34 and CD45 with flow cytometry analysis. RT-PCR showed not only positive expression of CD90, c-kit, Sca1, SH2 and SH3 but also positive expression of the chondrocyte markers Sox-9 and Col-2A1. WMSCs cultured in high-density in the presence of transforming growth factor b1 and dexamethasone showed cartilage extracellular matrix-secretion and integrated into a thin piece of cell-based membrane. The cell-based thin membrane cultured in rotary cell culture system formed a round, opaque, glistening non-scaffold cartilage-like tissue, larger and condenser than what was formed with conventional pellet culture. Glycosaminoglycan and type II collagen content significantly increased after 3-week culture. The human WMSCs express characteristics of pre-chondrocytes, low immunogenicity and are easy to be obtained with higher purity cells in Wharton’s jelly, so it may be a new seed cells more suitable for constructing tissue-engineered cartilage.

    Click on the link below to view this article.

  • Abstract

    Osteoarthritis is pandemic across the globe, with an estimated 30.8 million adults in the United States and 300 million individuals worldwide suffering with spine and/or joint pain and disability associated with osteoarthritis. Osteoarthritis is the most common form of degenerative disc and joint disease resulting in pathological pain, damage, and progressive breakdown of intra-articular joints between skeletal bones.

    Wharton’s Jelly is a specialized umbilical cord tissue whose primary function in the donor is to physically support and serve as a barrier or conduit, or connect, cover, and/or cushion. A compliant FDA registered 361 HCT/P harvested from Wharton’s Jelly is homologously utilized when injected into a qualified recipient’s intra-articular disc and/or joint(s) for the intended repair, reconstruction, replacement, and/or supplementation of the recipient’s damaged native cushion, protection, and structural support. These two safe and effective regenerative medicine procedures comprehensively qualify for regulation solely under section 361 of the PHS Act and 21 CFR part 1271 by fulfilling all four criteria in the 21 CFR 1271.10(a) checklist for exemption from the FDA’s high risk regulation and premarket approval requirements.

    Click on the link below to view this article.

  • Abstract

    The most recent studies indicate that exosomes can promote proliferation and migration of dermal fibroblasts and keratinocytes and enhance the angiogenesis process, leading to a strong regenerative effect on the skin injuries, both in normal and diabetic organisms. The replacement of stem cells with exosomes in the regenerative therapy has some advantages, such as the potential for drug and gene delivery, storage constancy, and stability in the body [87]. Moreover, a perpetual stem cell source can be obtained by immortalization and the nanovesicles isolation protocol can be standardized so that an “off the shelf” medicine would be available for chronic wounds treatment, as well as burns, which require immediate intervention. All these advantages bring light to the use of MSCs-derived exosomes as a new and effective approach in wound healing therapy without the confines that cellular therapy brings.

    Click on the link below to view this article.

  • Abstract

    The prognosis for extensive and deep skin injury is not satisfactory because of scar formation and the loss of normal function and skin appendages. Several novel therapies for skin repair and regeneration have emerged. Currently, stem cell–based therapies are attractive candidates in regenerative medicine to treat skin injuries. Human umbilical cord Wharton’s jelly–derived mesenchymal stem cells (hUC-MSCs) have become a unique, accessible, and noncontroversial source of regeneration in medicine. The aim of this study was to explore a new strategy for treating skin wounds. A mixture of hUC-MSCs, Wharton’s jelly, and skin microparticles were transplanted to 10-mm diameter, full-thickness, middorsal, excisional skin wounds of mice. After 7 days, the tissue sections were sampled for reconstruction analysis and histological examination. After transplantation, there was a remarkable development of newborn skin and its appendages. We could see newly generated layers of epidermis, sebaceous glands, hair follicle, and sweat glands clearly. This innovative strategy could be very promising and may significantly increase the quality of repair and regeneration of skin in injuries.

    Click on the link below to view this article.


  • Abstract

    Exosomes, a group of vesicles originating from the multivesicular bodies (MVBs), are released into the extracellular space when MVBs fuse with the plasma membrane. Numerous studies indicate that exosomes play important roles in cell-to-cell communication, and exosomes from specific cell types and conditions display multiple functions such as exerting positive effects on regeneration in many tissues. It is widely accepted that the therapeutic potential of stem cells may be mediated largely by the paracrine factors, so harnessing the paracrine effects of stem and progenitor cells without affecting these living, replicating, and potentially pluripotent cell populations is an advantage in terms of safety and complexity. Ascending evidence indicated that exosomes might be the main components of paracrine factors; thus, understanding the role of exosomes in each subtype of stem cells is far-reaching. In this review, we discuss the functions of exosomes from different types of stem cells and emphasize the therapeutic potentials of exosomes, providing an alternative way of developing strategies to cure diseases.

    Click on the link below to view this article.

  • Abstract

    The COVID-19 pandemic has placed an unprecedented burden on health care systems and economies around the globe.

    Clinical evidences demonstrate that SARS-CoV-2 infection produces detrimental levels of pro-inflammatory cytokines and chemokines that can lead to acute respiratory distress syndrome (ARDS) and significant systemic organ damage. Currently, there is no definitive therapy for COVID-19 or associated complications, and with the hope of a safe and effective vaccine in the distant future, the search for an answer is paramount. Mesenchymal stem cells (MSCs) provide a viable option due to their immunomodulatory effects and tissue repair and regeneration abilities. Studies have demonstrated that compassionate use of MSCs can reduce symptoms associated with SARS-CoV-2 infection, eliminate fluid buildup, and act as a regenerative technique for alveolar damage; all in a safe and effective way. With multiple autologous sources available for MSCs, each with their own respective limitations, allogenic umbilical cord (UC) and/or UC-derived Wharton’s jelly (WJ) seem to be best positioned source to harvest MSCs to treat COVID-19 and associated symptoms. As an allogenic source, UC is readily available, easily obtainable, and is rich in immunomodulatory and regenerative factors. 


    Click on the link below to view this article.


  • Stem Cells are undifferentiated cells that can turn into specific cells, as the body needs them. They have two characteristics:

    • They can replicate themselves, or;
    • They can differentiate into many other cell types, including bone, cartilage, muscle, nerves and connective tissue.

    Stem cell diagram 4

  • Exosomes are...

    micro-vesicles (30-150nm) that are involved in cell communication. This is a new frontier in regenerative medicine. These exosomes have been recently discovered to be involved in direct cell signaling. Exosomes are isolated from donated human mesenchymal stem cells (MSCs) and purified using our proprietary processing. The unique benefit to these exosomes is that they are stem cell-derived and bring a wide array of growth factors to stimulate and modulate many processes within the healing cascade. Exosomes are not cells but are micro-vesicles, which are about 1/1,000th the size of a cell and contain no nucleus or DNA. They can be regarded as the purest form of cellular therapy available, because their function is to direct tissue and wound healing by activating the patient’s own regenerative cell response. This is one of the latest generations of naturally bioactive stem cell-based products for patient treatment. Stem cells and stem cell therapy work by paracrine signaling (local cell-to-cell communication to induce changes in nearby cells) to create the appropriate healing environment to restore tissue. The exosomes are those paracrine signals isolated from stem cells that can be delivered without the need for delivering stem cells. As the technology and discovery of new methods of treating patients has evolved, the science shows that the optimal way to provide true “stem cell therapy” is to directly provide the signals as its own therapy and avoid potential issues with delivering and keeping transplanted cells alive. Stem cells by nature work to heal, repair, and restore the body. But, in some cases where there is a chronic abnormality, these cells fall into an inflammatory state, work in an unregulated capacity and inhibit healing. The 1000+growth factor proteins found to naturally occur in healthy tissue have shown to help modulate the inflammatory healing process. This is accomplished by activating and recruiting the patients “own cells” to the area, revascularizing the area and reducing the inflammatory response to allow natural healing.

  • Yes. VitaCell Biologics is an FDA registered tissue bank, specializing in the processing, storing and distribution of Umbilical Cord Tissue. We are an inspected and established HCT/P facility operating under the guidelines per the 21 CFR 1271.10 of the PHS Act, Section 361. We work closely with clinicians and practitioners strategically placed across the U.S. with the focus of enhancing lives through natural biologics, skincare and supplement products.

    Click on this link to see our FDA Registration:

  • Stem cells are progenitor cells which are capable of regeneration and differentiation into a wide range of specialized cell types. Once injected, stem cells follow inflammatory signals from damaged tissues and have multiple ways of repairing these damaged areas.

    The mesenchymal stem cells (MSCs), from the Umbilical Cord, are considered to be multipotent and can transform into different cell types.

    They act via anti-inflammatory activity, immune modulating capacity, and the ability to stimulate regeneration. We go through a very high throughput screening process to find cells that we know have the best anti-inflammatory activity, the best immune modulating capacity, and the best ability to stimulate regeneration.

  • At VitaCell Biologics, we utilize adult stem cells derived from Human Umbilical Cord Tissue. This has the highest source of mesenchymal stem cells (MSCs). These cells ideally assist in the treating of systemic autoimmune and inflammatory conditions. They also play a significant role in cellular signaling to repair and regenerate injured tissue.

  • The umbilical cord is processed in the hospital according to the rules and regulation of the American Association of Tissue Banks (AATB). Approximately 4 weeks prior to a scheduled caesarean section, the mothers OB/GYN asks her if she would like to keep and store her unborn child’s umbilical cord for future use. If the mother declines, then she is asked if she would like to donate the umbilical cord. If she agrees, she undergoes a review of her medical history, social history, and a blood test. If she is deemed an acceptable donor according to prevailing rules of the AATB, then at the time of her caesarean section, an experienced technician will clamp the umbilical cord, take it to a clean room and place it into a sterile collection bag. The bag of umbilical cord is then delivered to the lab for processing. Once at the lab, a sample of the umbilical cord tissue is sent to a 3rd party independent FDA registered lab for testing according to United States Pharmacopeia rule 71 (U.S.P. 71), which is a test for known communicable diseases. While that test is taking place, the stem cells are then processed and red blood cell products are removed. A sample of the finished stem cell product is then sent to a different 3rd party independent FDA registered lab for sterility testing. Only after both lab reports come back as “clean” and have passed the regulatory requirements, are the processed umbilical cord stem cells available for distribution.

  • Yes, as long as you store them at -80 C. We have commercially available -80 C freezers that will allow you to buy in bulk and have the cells available for immediate use. The freezer option will also save you shipping costs associated with multiple monthly shipments.

  • No, DNA testing is not necessary because the stem cells and mononucleated cells do NOT penetrate the nucleus of the recipients’ cells and thus do not pass on DNA. The ability of a stem cell to pass along DNA matter is a property of a stem cell when it is in the embryonic stage and is no longer possible after the 10th week of gestation. Umbilical cord stem cells are harvested between weeks 36 and 40.

  • The International Society for Cellular Therapy (ISCT) Says That the Presence of CD90, CD105, and CD73 are Necessary for the Identification of Stem Cells. Why do you Only Test for the Presence of CD90?

    The definition by the ISCT is for pure stem cells and not a heterogenous mix of stem cells and mononucleated cells that are used for umbilical cord stem cell therapies. It is also noted in literature that the presence of one or all the CD’s is consistent with the presence of stem cells is an indicator of stem cells. The reason we chose to test for CD90 is because it is the most clinically relevant for our purposes. CD90 is implicated in axonal growth, T-cell activation, cell adhesion, cell migration, and cell extravasation while CD105 is implicated in hematopoietic stem cell (HSC) function and CD73 is implicated in tumor suppression.

  • Research has shown that the vast majority of the function of stem cells is for Medicinal Signaling and NOT differentiation. Stem cells produce long-term effects by responding to signals from injured tissue. The stem cells work by inhibiting the inflammatory components that cause pain and damage to tissue and the mononucleated cells secrete growth factors, proteins, and cytokines that stimulate our own native tissue to repair and regenerate itself.

  • Yes, allogeneic (taken from another person of the same species) cells are safe to put into your body. When the umbilical cord is processed, all the red blood cell components that could cause a negative reaction are removed. Also, the umbilical cord cells are naïve/immature and do NOT react the way a mature adult cell would act.

    “Mesenchymal stem cells produce huge quantities of bio-molecules, some of which are immunosuppressive; MSC’s put up a curtain of molecules around themselves that allows donor (allogenic) MSC’s to be transplanted into a recipient, free from an immune response. (Immune privileged)”

    Arnold Caplan, PhD. Case Western Reserve University. Experimental and Molecular Medicine (2013) 45

    Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine

  • Yes, age definitely matters. In Vitro research by the International Journal of Molecular Sciences has shown that while young, vibrant umbilical cord stem cells can duplicate themselves every 28 hours for up to 65 generations or more, 50+ year old bone marrow aspirate and adipose derived stem cells duplicate at a much slower rate of 3 to 5 days for an average of only 11 to 13 generations. Also of note is that older cells undergo senescence (aging) at a much faster rate than young, vibrant umbilical cord cells and older senescent cells produce less quantities and less effective growth factors, proteins, and cytokines.

    Int. J. Mol. Sci. 2013, 14, 17986-18001; doi:10.3390/ijms140917986. International Journal of Molecular Sciences ISSN 1422-0067

  • Yes, you may mix/dilute the cells with PRP, which is isotonic and contains growth factors so it can increase the anti-inflammatory component.

    You may mix/dilute the cells with LACTATED RINGERS, normal saline (0.9%), or Hank’s Balanced Salt Solution. LACTATED RINGERS is readily available and causes minimal hyperosmolality. With normal saline, up to 10% to 15% of the cells could lyse. The lysed cells will still exert the function of the growth factors, by only the half-life of that growth factor, similar to amniotic fluid. (Cell death from the use of saline and thawing is considered when the cells are initially concentrated so that you will have the labeled number of cells after both processes)

  • Yes, 60%-70% is very good viability after thawing. In a clinical setting, (placing the vial in the palm of your hand for 3 to 4 minutes) viability of 50% to 70% is well documented as a good viability rate.

    VitaCell Biologics viability rate, after thawing, is in the high 90% range.

    *It should be noted that in a laboratory setting, cell viability, with all the technical and reagent advantages, can yield viability counts of over 90%.

    • Less invasive when compared to bone marrow / adipose aspiration
    • Less pain for the patient and much shorter procedure time
    • Umbilical Cord Wharton’s Jelly lack MHC-II and therefore are hypo-immunogenic
    • Fibroblast colony forming units are significantly higher in Umbilical Cord Wharton’s Jelly
    • Faster population rate
    • Have strong anti-inflammatory effect, reducing the expression of inflammatory cytokines
    • High concentration of peptides, hyaluronic acid and growth factors
    • Increases the likelihood for better patient outcomes
    • pain management
    • sports injuries
    • spinal conditions
    • podiatry
    • wound care
    • aesthetics
    • anti-aging
    • male enhancement
    • vaginal rejuvenation
    • hair restoration
    • Knee joint injury, tears of the meniscus
    • Hip and Shoulder pain
    • Chronic partial rotator cuff tears
    • Persistent partial tendon tears (tennis elbow, golfer’s elbow)
    • Plantar fasciitis (bone spurs)
    • Achilles tendonitis
    • Quadriceps and Patellar tendon tears
    • Muscular tears
    • Degenerative arthritis of the Knee, Hip, Shoulder or Ankle
    • Intervertebral disc and spinal facet joints
    • Sacroiliac joint pain
    • Greater trochanteric bursitis
    • Chronic neck pain, chronic back pain


Feel free to call us with any questions or inquiries at 855-696-CELL (2355). We would be happy to answer any questions you have regarding our services.  Also you are more than welcome to make an appointment to visit our Level 3 facility which exceeds all standards for excellence.  

1344 N Ellington Pkwy, Lewisberg, TN 37091

Privacy Policy

Your privacy is important to us. It is Vitacell Biologic's policy to respect your privacy regarding any information we may collect from you across our website, and other sites we own and operate.

We only ask for personal information when we truly need it to provide a service to you. We collect it by fair and lawful means, with your knowledge and consent. We also let you know why we’re collecting it and how it will be used.

We only retain collected information for as long as necessary to provide you with your requested service. What data we store, we’ll protect within commercially acceptable means to prevent loss and theft, as well as unauthorized access, disclosure, copying, use or modification.

We don’t share any personally identifying information publicly or with third-parties, except when required to by law.

Our website may link to external sites that are not operated by us. Please be aware that we have no control over the content and practices of these sites, and cannot accept responsibility or liability for their respective privacy policies.

You are free to refuse our request for your personal information, with the understanding that we may be unable to provide you with some of your desired services.

Your continued use of our website will be regarded as acceptance of our practices around privacy and personal information. If you have any questions about how we handle user data and personal information, feel free to contact us.

This policy is effective as of the 17th August 2022.


Terms of Use

1. Terms

By accessing this website, you are agreeing to be bound by these terms of service, all applicable laws and regulations, and agree that you are responsible for compliance with any applicable local laws. If you do not agree with any of these terms, you are prohibited from using or accessing this site. The materials contained in this website are protected by applicable copyright and trademark law.

2. Use License

  1. Permission is granted to temporarily download one copy of the materials (information or software) on Vitacell Biologics' website for personal, non-commercial transitory viewing only. This is the grant of a license, not a transfer of title, and under this license you may not:
    1. modify or copy the materials;
    2. use the materials for any commercial purpose, or for any public display (commercial or non-commercial);
    3. attempt to decompile or reverse engineer any software contained on Vitacell Biologics' website;
    4. remove any copyright or other proprietary notations from the materials; or
    5. transfer the materials to another person or "mirror" the materials on any other server.
  2. This license shall automatically terminate if you violate any of these restrictions and may be terminated by Vitacell Biologics at any time. Upon terminating your viewing of these materials or upon the termination of this license, you must destroy any downloaded materials in your possession whether in electronic or printed format.

3. Disclaimer

  1. The materials on Vitacell Biologics' website are provided on an 'as is' basis.  Vitacell Biologics makes no warranties, expressed or implied, and hereby disclaims and negates all other warranties including, without limitation, implied warranties or conditions of merchantability, fitness for a particular purpose, or non-infringement of intellectual property or other violation of rights.
  2. Further, Vitacell Biologics does not warrant or make any representations concerning the accuracy, likely results, or reliability of the use of the materials on its website or otherwise relating to such materials or on any sites linked to this site.

4. Limitations

In no event shall Vitacell Biologics or its suppliers be liable for any damages (including, without limitation, damages for loss of data or profit, or due to business interruption) arising out of the use or inability to use the materials on Vitacell Biologics' website, even if Vitacell Biologics or a Vitacell Biologics authorized representative has been notified orally or in writing of the possibility of such damage. Because some jurisdictions do not allow limitations on implied warranties, or limitations of liability for consequential or incidental damages, these limitations may not apply to you.

5. Accuracy of materials

The materials appearing on Vitacell Biologics' website could include technical, typographical, or photographic errors. Vitacell Biologics does not warrant that any of the materials on its website are accurate, complete or current.  Vitacell Biologics may make changes to the materials contained on its website at any time without notice. However, Vitacell Biologics does not make any commitment to update the materials.

6. Links

Vitacell Biologics has not reviewed all of the sites linked to its website and is not responsible for the contents of any such linked site. The inclusion of any link does not imply endorsement by Vitacell Biologics of the site. Use of any such linked website is at the user's own risk.

7. Modifications

Vitacell Biologics may revise these terms of service for its website at any time without notice. By using this website you are agreeing to be bound by the then current version of these terms of service.

8. Governing Law

These terms and conditions are governed by and construed in accordance with the laws of Florida and you irrevocably submit to the exclusive jurisdiction of the courts in that State or location.